Symposium on arteriosclerotic heart disease. Tachyarrhythmias. Differential diagnosis and therapy after acute myocardial infarction.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D002395:Catecholamines / Q000097:blood; D003937:Diagnosis, Differential; D004077:Digoxin / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000175:diagnosis*; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D002395:Catecholamines; D004077:Digoxin; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide; D011188:Potassium